Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07783373 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT07783373 · ClinicalTrials.gov record · last posted 2026-08-24

Long-Term Real-World Safety of Cobenfy in Adults With Schizophrenia

Name: Long-Term Real-World Safety of Cobenfy in Adults With Schizophrenia — clinical trial record (NCT07783373)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhaseNot specified

SponsorBristol-Myers Squibb

Started2026-05-01

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This study will evaluate the long-term real-world safety of xanomeline-trospium chloride in adults with schizophrenia receiving routine clinical care in the United States.

Trial Details

NCT Number	NCT07783373
Lead Sponsor	Bristol-Myers Squibb
Conditions	Schizophrenia
Enrollment	3,000 participants
Start Date	2026-05-01
Primary Completion	2027-09-26 (estimated)
Study Completion	2028-04-26 (estimated)
Updated on ClinicalTrials.gov	2026-08-24